ZANTAC LAWSUIT WHITEPAPER
Zantac is Available by Prescription, or Over-the-Counter
Zantac is a pharmaceutical drug used to treat various intestinal issues. The main active ingredient is ranitidine. Zantac is available in two ways, prescription or over the counter.
Over the counter versions of ranitidine are used to treat mild cases of heartburn and can be purchased by anyone. Prescription Zantac has higher levels of ranitidine and is used to treat more severe intestinal conditions, like ulcers.
Zantac Contains Contaminants
Large amounts of NDMA were found in Zantac, which is classified as a human carcinogen. Research indicates that upon raising temperatures, the impurities in NDMA also increase. Due to this issue, many people are reporting illnesses from taking Zantac or other ranitidine products.
FDA Steps In
On April 1st, 2020, the FDA sent out a notice requiring the urgent removal of all forms of Zantac and other ranitidine products containing elevated levels of NDMA. The recall instructed all retailers, manufacturers, doctors, and people taking the drug (with doctor’s assistance in stopping) to remove the drug or dispose of it.
Zantac Physical Side-Effects
- Liver cancer (non-drinker)
- Stomach cancer
- Esophageal cancer (non-smoker)
- Bladder cancer
- Pancreatic cancer
Zantac Status of Court Cases
Cases have been consolidated in the Southern District of Florida. The MDL number for Zantac is 2924 with Judge Robin L Rosenberg presiding. The Judicial Panel for Multidistrict Litigation was formed on February 6, 2020. There have been no verdicts or known settlements at this time.
Who Makes Zantac?
The companies are currently being prosecuted for their products are:
- Boehringer Ingelheim Pharmaceuticals, Inc.;
- GlaxoSmithKline LLC; Pfizer Inc.;
- Sanofi-Aventis U.S. LLC;
- Sanofi US Services Inc.; and,
- Chattem, Inc.